165 related articles for article (PubMed ID: 38636590)
1. Expanded Newborn Screening for Inborn Errors of Immunity: The Experience of Tuscany.
Ricci S; Guarnieri V; Capitanini F; Pelosi C; Astorino V; Boscia S; Calistri E; Canessa C; Cortimiglia M; Lippi F; Lodi L; Malvagia S; Moriondo M; La Marca G; Azzari C
J Allergy Clin Immunol Pract; 2024 Jun; 12(6):1622-1630.e4. PubMed ID: 38636590
[TBL] [Abstract][Full Text] [Related]
2. Newborn Screening for Severe T and B Cell Lymphopenia Using TREC/KREC Detection: A Large-Scale Pilot Study of 202,908 Newborns.
Marakhonov AV; Efimova IY; Mukhina AA; Zinchenko RA; Balinova NV; Rodina Y; Pershin D; Ryzhkova OP; Orlova AA; Zabnenkova VV; Cherevatova TB; Beskorovainaya TS; Shchagina OA; Polyakov AV; Markova ZG; Minzhenkova ME; Shilova NV; Larin SS; Khadzhieva MB; Dudina ES; Kalinina EV; Mudaeva DA; Saydaeva DH; Matulevich SA; Belyashova EY; Yakubovskiy GI; Tebieva IS; Gabisova YV; Irinina NA; Nurgalieva LR; Saifullina EV; Belyaeva TI; Romanova OS; Voronin SV; Shcherbina A; Kutsev SI
J Clin Immunol; 2024 Apr; 44(4):93. PubMed ID: 38578360
[TBL] [Abstract][Full Text] [Related]
3. Diagnosis of immunodeficiency caused by a purine nucleoside phosphorylase defect by using tandem mass spectrometry on dried blood spots.
la Marca G; Canessa C; Giocaliere E; Romano F; Malvagia S; Funghini S; Moriondo M; Valleriani C; Lippi F; Ombrone D; Della Bona ML; Speckmann C; Borte S; Brodszki N; Gennery AR; Weinacht K; Celmeli F; Pagel J; de Martino M; Guerrini R; Wittkowski H; Santisteban I; Bali P; Ikinciogullari A; Hershfield M; Notarangelo LD; Resti M; Azzari C
J Allergy Clin Immunol; 2014 Jul; 134(1):155-9. PubMed ID: 24767876
[TBL] [Abstract][Full Text] [Related]
4. The successful inclusion of ADA SCID in Tuscany expanded newborn screening program.
Malvagia S; Funghini S; Della Bona M; Ombrone D; Mura M; Damiano R; Ricci S; Cortimiglia M; Azzari C; la Marca G
Clin Chem Lab Med; 2021 Sep; 59(10):e401-e404. PubMed ID: 33951760
[No Abstract] [Full Text] [Related]
5. High Incidence of Severe Combined Immunodeficiency Disease in Saudi Arabia Detected Through Combined T Cell Receptor Excision Circle and Next Generation Sequencing of Newborn Dried Blood Spots.
Al-Mousa H; Al-Dakheel G; Jabr A; Elbadaoui F; Abouelhoda M; Baig M; Monies D; Meyer B; Hawwari A; Dasouki M
Front Immunol; 2018; 9():782. PubMed ID: 29713328
[TBL] [Abstract][Full Text] [Related]
6. TREC/KREC Newborn Screening followed by Next-Generation Sequencing for Severe Combined Immunodeficiency in Japan.
Wakamatsu M; Kojima D; Muramatsu H; Okuno Y; Kataoka S; Nakamura F; Sakai Y; Tsuge I; Ito T; Ueda K; Saito A; Morihana E; Ito Y; Ohashi N; Tanaka M; Tanaka T; Kojima S; Nakajima Y; Ito T; Takahashi Y
J Clin Immunol; 2022 Nov; 42(8):1696-1707. PubMed ID: 35902420
[TBL] [Abstract][Full Text] [Related]
7. Newborn screening for severe T and B cell immunodeficiency in Israel: a pilot study.
Somech R; Lev A; Simon AJ; Korn D; Garty BZ; Amariglio N; Rechavi G; Almashanu S; Zlotogora J; Etzioni A
Isr Med Assoc J; 2013 Aug; 15(8):404-9. PubMed ID: 24079059
[TBL] [Abstract][Full Text] [Related]
8. Newborn screening for severe combined immunodeficiency: Evaluation of a commercial T-cell receptor excision circle-based method in Victorian dried blood spots.
Richards S; Pitt J; Choo S
J Paediatr Child Health; 2018 Jan; 54(1):14-19. PubMed ID: 28861919
[TBL] [Abstract][Full Text] [Related]
9. Newborn screening for severe combined immunodeficiency and inborn errors of immunity.
Lev A; Somech R; Somekh I
Curr Opin Pediatr; 2023 Dec; 35(6):692-702. PubMed ID: 37707504
[TBL] [Abstract][Full Text] [Related]
10. Newborn Screening for Severe Primary Immunodeficiency Diseases in Sweden-a 2-Year Pilot TREC and KREC Screening Study.
Barbaro M; Ohlsson A; Borte S; Jonsson S; Zetterström RH; King J; Winiarski J; von Döbeln U; Hammarström L
J Clin Immunol; 2017 Jan; 37(1):51-60. PubMed ID: 27873105
[TBL] [Abstract][Full Text] [Related]
11. Newborn Screening for SCID and Other Severe Primary Immunodeficiency in the Polish-German Transborder Area: Experience From the First 14 Months of Collaboration.
Giżewska M; Durda K; Winter T; Ostrowska I; Ołtarzewski M; Klein J; Blankenstein O; Romanowska H; Krzywińska-Zdeb E; Patalan MF; Bartkowiak E; Szczerba N; Seiberling S; Birkenfeld B; Nauck M; von Bernuth H; Meisel C; Bernatowska EA; Walczak M; Pac M
Front Immunol; 2020; 11():1948. PubMed ID: 33178177
[TBL] [Abstract][Full Text] [Related]
12. Determining T and B Cell development by TREC/KREC analysis in primary immunodeficiency patients and healthy controls.
Şentürk G; Ng YY; Eltan SB; Başer D; Ogulur I; Altındirek D; Fırtına S; Yılmaz H; Kocamış B; Kıykım A; Camcıoğlu Y; Ar MC; Sudutan T; Beken S; Temel ŞG; Alanay Y; Karakoc-Aydiner E; Barış S; Özen A; Özbek U; Sayitoğlu M; Hatırnaz Ng Ö
Scand J Immunol; 2022 Mar; 95(3):e13130. PubMed ID: 34951041
[TBL] [Abstract][Full Text] [Related]
13. Newborn Screening through TREC, TREC/KREC System for Primary Immunodeficiency with limitation of TREC/KREC. Comprehensive Review.
Shinwari K; Bolkov M; Tuzankina IA; Chereshnev VA
Antiinflamm Antiallergy Agents Med Chem; 2021; 20(2):132-149. PubMed ID: 32748762
[TBL] [Abstract][Full Text] [Related]
14. Newborn screening for severe combined immunodeficiency: The results of the first pilot TREC and KREC study in Ukraine with involving of 10,350 neonates.
Boyarchuk O; Yarema N; Kravets V; Shulhai O; Shymanska I; Chornomydz I; Hariyan T; Volianska L; Kinash M; Makukh H
Front Immunol; 2022; 13():999664. PubMed ID: 36189201
[TBL] [Abstract][Full Text] [Related]
15. Second Tier Testing to Reduce the Number of Non-actionable Secondary Findings and False-Positive Referrals in Newborn Screening for Severe Combined Immunodeficiency.
Blom M; Pico-Knijnenburg I; Imholz S; Vissers L; Schulze J; Werner J; Bredius R; van der Burg M
J Clin Immunol; 2021 Nov; 41(8):1762-1773. PubMed ID: 34370170
[TBL] [Abstract][Full Text] [Related]
16. Neonatal screening for severe primary immunodeficiency diseases using high-throughput triplex real-time PCR.
Borte S; von Döbeln U; Fasth A; Wang N; Janzi M; Winiarski J; Sack U; Pan-Hammarström Q; Borte M; Hammarström L
Blood; 2012 Mar; 119(11):2552-5. PubMed ID: 22130802
[TBL] [Abstract][Full Text] [Related]
17. Newborn tandem mass spectroscopy screening for adenosine deaminase deficiency.
Hartog N; Hershfield M; Michniacki T; Moloney S; Holsworth A; Hurden I; Fredrickson M; Kleyn M; Walkovich K; Secord E
Ann Allergy Asthma Immunol; 2022 Dec; 129(6):776-783.e2. PubMed ID: 35914665
[TBL] [Abstract][Full Text] [Related]
18. Tandem mass spectrometry, but not T-cell receptor excision circle analysis, identifies newborns with late-onset adenosine deaminase deficiency.
la Marca G; Canessa C; Giocaliere E; Romano F; Duse M; Malvagia S; Lippi F; Funghini S; Bianchi L; Della Bona ML; Valleriani C; Ombrone D; Moriondo M; Villanelli F; Speckmann C; Adams S; Gaspar BH; Hershfield M; Santisteban I; Fairbanks L; Ragusa G; Resti M; de Martino M; Guerrini R; Azzari C
J Allergy Clin Immunol; 2013 Jun; 131(6):1604-10. PubMed ID: 23280131
[TBL] [Abstract][Full Text] [Related]
19. Can we identify WHIM in infancy? Opportunities with the public newborn screening process.
Yilmaz M; Potts DE; Geier C; Walter JE
Am J Med Genet C Semin Med Genet; 2022 Jun; 190(2):215-221. PubMed ID: 36210583
[TBL] [Abstract][Full Text] [Related]
20. Screening for and treatments of congenital immunodeficiency diseases.
Verbsky J; Routes J
Clin Perinatol; 2014 Dec; 41(4):1001-15. PubMed ID: 25459787
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
